Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

A Laotian man with unusual skin changes and multiple growths in his gut was diagnosed with Cronkhite-Canada Syndrome and improved with nutritional and immune-based treatments.

NK cells play a role in skin diseases like eczema and psoriasis.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

New therapies are being developed that target integrin pathways to treat various diseases.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Healthy scalp reduces hair loss by managing oxidative stress.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Social media can help compare the effectiveness and safety of new arthritis medications.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.